Carna Biosciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3220550002
JPY
371.00
67 (22.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
2,475.35
3,877.53
3,641.84
4,315.57
3,824.01
3,853.52
Shareholder's Funds
2,475.35
3,877.53
3,641.84
4,315.57
3,824.01
3,853.52
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
36.51
154.97
300.39
539.89
429.78
728.76
Secured Loans
36.51
154.97
300.39
539.89
429.78
728.76
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
1.27
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
65.38
68.03
39.8
41.94
44.26
38.14
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
39.29
38.66
38.04
37.43
36.84
36.26
Total Non-Current Liabilities
73.79
96.43
188.20
342.33
284.15
467.92
Current Liabilities
Trade Payables
2.00
1.20
1.96
2.29
1.52
3.17
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
39.29
38.66
38.04
37.43
36.84
36.26
Total Current Liabilities
222.97
375.92
436.41
774.65
727.19
1,055.16
Total Liabilities
2,772.11
4,349.89
4,266.45
5,432.56
4,835.35
5,376.61
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
978.13
961.77
997.05
893.81
892.24
831.01
Less: Accumulated Depreciation
978.13
856.27
896.82
842.23
838.91
801.21
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
0.00
105.50
100.23
51.57
53.33
29.80
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
1.14
2.30
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
34.40
51.82
59.99
58.62
67.92
71.68
Total Non-Current Assets
34.40
158.41
162.14
114.07
127.16
101.72
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
154.15
140.14
118.53
110.49
104.52
99.41
Sundry Debtors
87.09
788.20
182.43
1,243.84
129.18
117.50
Cash and Bank
2,108.48
2,889.10
3,379.05
3,817.83
4,299.14
4,915.06
Other Current Assets
2,349.72
3,817.44
3,680.01
5,172.16
4,532.84
5,131.97
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
2,737.72
4,191.48
4,104.32
5,318.49
4,708.19
5,274.89
Net Current Assets (Including Current Investments)
2,514.75
3,815.56
3,667.91
4,543.83
3,981.00
4,219.73
Total Current Assets Excluding Current Investments
2,737.72
4,191.48
4,104.32
5,318.49
4,708.19
5,274.89
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,772.11
4,349.89
4,266.45
5,432.56
4,835.36
5,376.61
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
36.51
154.97
300.39
539.89
429.78
728.76
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is -70.39% vs -80.86% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -3.90% vs 70.93% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -100.00% vs 5.26% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is -34.68% vs 2.12% in Dec 2023

Compare Balance Sheet Results of Carna Biosciences, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
2,475.35
2,627.85
-152.50
-5.80%
Shareholder's Funds
2,475.35
2,627.85
-152.50
-5.80%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
36.51
504.82
-468.31
-92.77%
Secured Loans
36.51
504.82
-468.31
-92.77%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
1.27
-60.19
61.46
102.11%
Other Long Term Liabilities
65.38
117.45
-52.07
-44.33%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
39.29
103.30
-64.01
-61.97%
Total Non-Current Liabilities
73.79
555.04
-481.25
-86.71%
Current Liabilities
Trade Payables
2.00
24.93
-22.93
-91.98%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
39.29
103.30
-64.01
-61.97%
Total Current Liabilities
222.97
4,318.05
-4,095.08
-94.84%
Total Liabilities
2,772.11
7,500.94
-4,728.83
-63.04%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
978.13
1,837.63
-859.50
-46.77%
Less: Accumulated Depreciation
978.13
682.07
296.06
43.41%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
0.00
1,155.56
-1,155.56
-100.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
819.38
-819.38
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
34.40
156.41
-122.01
-78.01%
Total Non-Current Assets
34.40
2,328.47
-2,294.07
-98.52%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
154.15
50.98
103.17
202.37%
Sundry Debtors
87.09
1,836.38
-1,749.29
-95.26%
Cash and Bank
2,108.48
3,200.85
-1,092.37
-34.13%
Other Current Assets
2,349.72
5,088.21
-2,738.49
-53.82%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
2,737.72
5,172.47
-2,434.75
-47.07%
Net Current Assets (Including Current Investments)
2,514.75
854.42
1,660.33
194.32%
Total Current Assets Excluding Current Investments
2,737.72
5,172.47
-2,434.75
-47.07%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
2,772.11
7,500.94
-4,728.83
-63.04%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
36.51
504.82
-468.31
-92.77%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 8.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -70.39% vs -80.86% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 65.38 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.90% vs 70.93% in Dec 2023

Annual - Fixed Assets
Fixed Assets 0.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -100.00% vs 5.26% in Dec 2023

Annual - Investments
Investments 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 2,737.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -34.68% vs 2.12% in Dec 2023